Literature DB >> 8615613

DNA lesion-recognizing proteins and the p53 connection.

T Boulikas1.   

Abstract

A great deal of the energy and time of a cell is invested in DNA repair activities. The first step in DNA repair pathways is recognition of the lesion on the DNA. The classical lesion-recognizing proteins interact with other repair proteins to form multiprotein complexes most notable of which are those that function in Nucleotide Excision Repair (NER). Proteins involved in lesion recognition include HMG1 and 2 recognizing cisplatin adducts but also maintaining active nucleosome structures and interacting with loops in cruciforms; HMG-box nuclear proteins; XPA and XPC lacking in xeroderma pigmentosum patients and involved in lesion recognition during NER; p53 recognizing strand breaks and insertion/deletion mismatches and causing arrest in the cell cycle; MSH2 mismatch repair protein identified as the human colon cancer gene product; and others including the transcription factor YB-1 that binds to depurinated DNA with a higher affinity compared with undamaged DNA. Other type of lesion-recognizing proteins are also repair enzymes like the O(6)-methylguanine-DNA methyltransferase and DNA glycosylases. Lesion recognition is an important process and might be the rate-limiting step in the overall repair process.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8615613

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Physical and functional interaction between the Y-box binding protein YB-1 and human polyomavirus JC virus large T antigen.

Authors:  M Safak; G L Gallia; S A Ansari; K Khalili
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  Differentiation-dependent p53 regulation of nucleotide excision repair in keratinocytes.

Authors:  G Li; V C Ho; D L Mitchell; M J Trotter; V A Tron
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

3.  TATA binding protein discriminates between different lesions on DNA, resulting in a transcription decrease.

Authors:  F Coin; P Frit; B Viollet; B Salles; J M Egly
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

4.  Depletion of the cisplatin targeted HMGB-box factor UBF selectively induces p53-independent apoptotic death in transformed cells.

Authors:  Nourdine Hamdane; Chelsea Herdman; Jean-Clement Mars; Victor Stefanovsky; Michel G Tremblay; Tom Moss
Journal:  Oncotarget       Date:  2015-09-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.